Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry. J of Skin. 2024;8(6):s463. doi:10.25251/skin.8.supp.463